An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211403
Company: DR REDDYS

Products on ANDA 211403

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211403

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/31/2020	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 211403

DAPTOMYCIN

POWDER;INTRAVENOUS; 350MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	212667	ACCORD HLTHCARE
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	216445	ASPIRO
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	213425	BE PHARMS
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	211403	DR REDDYS
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	213786	MEITHEAL
DAPTOMYCIN	DAPTOMYCIN	350MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	208385	SAGENT PHARMS INC

Top